Torrent Expects India Ruling On AZ's Farxiga In Q3

Starting Afresh In Sartans

With the India business on the road to recovery and the US growth outlook muted, Torrent hopes to keep the boat steady in fiscal 2021. It also expects an order in Q3 in a patent infringement case pertaining to AstraZeneca’s Farxiga, where it and multiple Indian firms are seeking to launch generic versions.

Wooden judge gavel with drugs on table
AstraZeneca's Patent Infringement Case Against Torrent And Others In The Courts • Source: Shutterstock

Hoping to launch its own brand of a dapagliflozin generic in India, Torrent Pharmaceuticals Ltd. expects a court order in AstraZeneca Pharma India Ltd.’s case regarding the diabetes drug against multiple Indian companies, including itself, during the third quarter.

AstraZeneca PLC sells the drug as Forxiga in India and as Farxiga elsewhere and though the basic patent expired...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip